The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions

被引:19
作者
Atkin, Catherine [1 ]
Reddy-Kolanu, Vinay [2 ]
Drayson, Mark T. [3 ]
Sapey, Elizabeth [1 ]
Richter, Alex G. [3 ]
机构
[1] Univ Birmingham, Inst Inflammat & Ageing, Birmingham Acute Care Res, Birmingham B15 2GW, W Midlands, England
[2] Queen Elizabeth Hosp, Dept Acute Med, Birmingham, W Midlands, England
[3] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
关键词
monoclonal gammopathy of undetermined significance; acute medicine; infection; screening; renal dysfunction; CHAIN DEPOSITION DISEASE; MULTIPLE-MYELOMA; SIGNIFICANCE MGUS; GUIDELINES; MANAGEMENT; RISK; DIAGNOSIS; PROGRESSION; SURVIVAL; THERAPY;
D O I
10.1111/bjh.16487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monoclonal gammopathy of undetermined significance (MGUS) affects 3 center dot 2% of adults aged >50 years. MGUS carries a life-long risk of progression to multiple myeloma and causes complications including infection and renal impairment; common causes of hospital admission. This study aimed to assess MGUS prevalence in emergency medical hospital admissions. Patients were recruited from unselected emergency medical admissions in a hospital in the United Kingdom. Serum protein electrophoresis was performed, with immunofixation of abnormal results. Reason for admission and routine test results were recorded. After education about MGUS and myeloma, patients chose whether they wished to be informed of new diagnoses. A total of 660 patients were tested and 35 had a paraprotein suggestive of MGUS. The overall rate of MGUS was 5 center dot 3%. MGUS prevalence in those aged >50 years was 6 center dot 94%, higher than the previously published rate of 3 center dot 2% (P < 0 center dot 0005). There were higher rates in those with chronic kidney disease (13 center dot 75% vs. 4 center dot 14%, P = 0 center dot 002), heart failure (14% vs. 4 center dot 59%, P = 0 center dot 012), anaemia (8 center dot 96% vs. 3 center dot 41%, P = 0 center dot 003) or leucocytosis (9 center dot 33% vs. 3 center dot 04%, P = 0 center dot 002). In all, 96% of patients wished to be informed of their screening results. The prevalence of MGUS in emergency hospital admissions is higher than expected based on previous population-based rates. This may suggest a selected population for screening.
引用
收藏
页码:1127 / 1135
页数:9
相关论文
共 39 条
[1]   Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece [J].
Anagnostopoulos, A ;
Evangelopoulou, A ;
Sotou, D ;
Gika, D ;
Mitsibounas, D ;
Dimopoulos, MA .
ANNALS OF HEMATOLOGY, 2002, 81 (07) :357-361
[2]  
[Anonymous], 2015, Hospital Episode Statistics
[3]   What is the significance of monoclonal gammopathy of undetermined significance? [J].
Atkin, Catherine ;
Richter, Alex ;
Sapey, Elizabeth .
CLINICAL MEDICINE, 2018, 18 (05) :391-396
[4]   Guidelines for the diagnosis and management of multiple myeloma 2011 [J].
Bird, Jennifer M. ;
Owen, Roger G. ;
D'Sa, Shirley ;
Snowden, John A. ;
Pratt, Guy ;
Ashcroft, John ;
Yong, Kwee ;
Cook, Gordon ;
Feyler, Sylvia ;
Davies, Faith ;
Morgan, Gareth ;
Cavenagh, Jamie ;
Low, Eric ;
Behrens, Judith .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (01) :32-75
[5]   UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS) [J].
Bird, Jenny ;
Behrens, Judith ;
Westin, Jan ;
Turesson, Ingemar ;
Drayson, Mark ;
Beetham, Robert ;
D'Sa, Shirley ;
Soutar, Richard ;
Waage, Anders ;
Gulbrandsen, Nina ;
Gregersen, Henrik ;
Low, Eric .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (01) :22-42
[6]   Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia [J].
Bladé, J ;
Kyle, RA .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (06) :1259-+
[7]   The safety implications of missed test results for hospitalised patients: a systematic review [J].
Callen, Joanne ;
Georgiou, Andrew ;
Li, Julie ;
Westbrook, Johanna I. .
BMJ QUALITY & SAFETY, 2011, 20 (02) :194-199
[8]  
*CANC RES UK, 2017, MYEL STAT
[9]   Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study [J].
Dispenzieri, Angela ;
Katzmann, Jerry A. ;
Kyle, Robert A. ;
Larson, Dirk R. ;
Melton, L. Joseph, III ;
Colby, Colin L. ;
Therneau, Terry M. ;
Clark, Raynell ;
Kumar, Shaji K. ;
Bradwell, Arthur ;
Fonseca, Rafael ;
Jelinek, D. F. ;
Rajkumar, S. Vincent .
LANCET, 2010, 375 (9727) :1721-1728
[10]   Diagnosing acute brain dysfunction due to sepsis [J].
Esen, Figen ;
Orhun, Gunseli ;
Ozcan, Perihan Ergin ;
Brenes Bastos, Andres R. ;
Tuzun, Erdem .
NEUROLOGICAL SCIENCES, 2020, 41 (01) :25-33